LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery
May 8, 2026
DÜSSELDORF, Germany -- LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will integrate our ALiCE® platform with Twist’s DNA manufacturing and automation capabilities to accelerate the design–build–test cycle for protein expression services—delivering experimental results back to customers’ and partners’ AI [...]
LNI Swissgas to Become Part of Velaris Platform
May 8, 2026
LNI Swissgas is pleased to announce its acquisition by Velaris, a platform of leading laboratory automation and analytical technology brands backed by Battery Ventures. This milestone marks an exciting new chapter for LNI Swissgas and supports the company’s long-term strategy for international growth, innovation and expanded customer support capabilities. For more than 30 years, LNI [...]
May 7, 2026
Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure. TORONTO, Ontario — DNAstack and PhenoTips today announced an integrated platform that runs clinical genetics workflows, from patient intake and phenotyping to genomic interpretation and diagnostic report, entirely on Canadian infrastructure. At a time [...]
May 7, 2026
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The [...]
May 7, 2026
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The [...]
May 7, 2026
The company joins the Velaris family of existing brands – Skalar Analytical, LCTech, PromoChrom, EST Analytical, GERSTEL, Trace Elemental Instruments and Markes – expanding Velaris’ product and service capabilities and global presence BREDA, The Netherlands – Velaris, a platform of laboratory-automation brands backed by global investment firm Battery Ventures, today announced the acquisition of LNI [...]
May 7, 2026
GPU-Accelerated Platform Unifies Fragmented Workflows, Turning Weeks of Analysis into Minutes ANN ARBOR, Mich. -- Advaita Bio today announced the launch of iSCanGuide, a cloud-based platform engineered to transform large-scale single-cell and spatial transcriptomics datasets into biologically meaningful results. Built on 20 years of validated science, the platform is integrated with Advaita's flagship platform, iPathwayGuide™, replacing fragmented workflows [...]
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows
May 6, 2026
Combines validated scientific engines with accelerated computing and AI to enable more scalable, integrated modeling workflows across the drug development lifecycle RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a [...]
Uncountable Expands Specialty Chemicals Footprint with Four New Deals
May 6, 2026
AI Platform Unifies Formulation, Scale-up, and Production Data to Accelerate End-to-End Specialty Chemicals Development SAN FRANCISCO – Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed four new agreements with specialty chemicals organizations to support formulation development, scale-up, and production optimization. The new deals underscore Uncountable’s continued [...]
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
May 6, 2026
Strategic acquisition adds integrated hardware and cloud subscription platform powered by NIR spectroscopy BURLINGTON, Mass. -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland. The company delivers AI-powered, cloud-connected near-infrared (NIR) spectroscopy to [...]

